Online citations, reference lists, and bibliographies.
← Back to Search

How Antidepressant Drugs Act: A Primer On Neuroplasticity As The Eventual Mediator Of Antidepressant Efficacy

C. Andrade, N. Rao
Published 2010 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Depression is conventionally viewed as a state of chemical imbalance, and antidepressants are suggested to act through increasing monoaminergic neurotransmission. These views are currently considered simplistic. This article examines the animal and human literature on the neurohistological mechanisms underlying stress, depression and antidepressant treatment. Pathological stress and depression are associated with changes such as loss of dendritic spines, shrinkage of the dendritic tree and loss of synapses in the hippocampus and prefrontal cortex. There is also a decrease in glia. Apoptosis may occur under extreme circumstances. In contrast, there is increased dendritic arborization and synaptogenesis in the amygdala. Antidepressant treatment protects against and even reverses some but not all of these stress-induced neurohistological changes. Pathological stress results in an aberrant neuroplasticity response characterized by abnormally increased activity in the amygdala and by impaired functioning of the hippocampus, prefrontal cortex and downstream structures. This aberrant neuroplasticity response directly explains most of the clinical symptoms of depression. Antidepressant treatment protects against stress-induced pathoplastic neurohistological and neurocognitive changes. Antidepressant treatment also restores functional neuroplasticity in stressed organisms and, thereby, presumably, facilitates re-adaptation through learning and memory mechanisms. Thus, the stress–depression syndrome and the therapeutic and prophylactic efficacy of antidepressant treatments can be explained through a hardwiring analogy. In this context, glutamate is an important neurotransmitter.
This paper references
Further Characterization of Mania as a Side Effect of ECT.
C. Andrade (1990)
10.1016/S0006-3223(00)00228-6
Increased neurogenesis in a model of electroconvulsive therapy
T. Madsen (2000)
10.1001/ARCHPSYC.57.10.925
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
R. Sapolsky (2000)
10.1006/exnr.2000.7458
Neurogenesis in the Dentate Gyrus of the Rat Following Electroconvulsive Shock Seizures
B. Scott (2000)
[Animal models of depression].
A. Damjanović (2000)
10.1001/ARCHPSYC.57.1.14
Is depression an adaptation?
R. Nesse (2000)
10.1515/REVNEURO.2002.13.1.59
Corticosteroids: Sculptors of the Hippocampal Formation
N. Sousa (2002)
10.1016/S0306-4522(01)00477-8
Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat
D. McCullers (2002)
10.1034/J.1399-5618.2002.01203.X
Antidepressants and neuroplasticity.
C. D'Sa (2002)
10.1016/S0006-3223(02)01432-4
An open label trial of C-1073 (mifepristone) for psychotic major depression*
J. Belanoff (2002)
10.1046/j.1460-9568.2002.02093.x
Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment
J. Hellsten (2002)
10.1097/00001756-200409150-00022
Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801
F. Fumagalli (2004)
10.1016/j.euroneuro.2004.09.003
Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression
D. Diamond (2004)
10.1038/sj.npp.1300471
Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder
A. Young (2004)
Consequences of depression in the hippocampus and other brain regions
YI Sheline (2004)
Introduction: Theories of depression - from monoamines to neuroplasticity
RS Duman (2004)
10.1016/j.brainres.2005.09.043
Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress
Can Luo (2005)
Handbook of Psychiatry: A South Asian perspective.
D. Bhugra (2005)
10.1038/sj.npp.1300565
Electroconvulsive Seizure Treatment Increases Cell Proliferation in Rat Frontal Cortex
T. Madsen (2005)
10.1001/ARCHPSYC.63.10.1121
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
M. Furey (2006)
10.1001/ARCHPSYC.63.8.856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
C. Zarate (2006)
10.1124/PR.58.1.7
Signaling Pathways Regulating Gene Expression, Neuroplasticity, and Neurotrophic Mechanisms in the Action of Antidepressants: A Critical Overview
D. Tardito (2006)
10.1016/j.biopsych.2005.11.019
Region Specific Hypothalamic Neuronal Activation and Endothelial Cell Proliferation in Response to Electroconvulsive Seizures
L. Jansson (2006)
10.1038/mp.2008.57
Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies
J. Hamilton (2008)
Comprar Stahl's Essential Psychopharmacology. Neuroscientific Basis and Practical Applications | Stephen M. Stahl | 9780521857024 | Cambridge University Press
S. Stahl (2008)
10.1038/sj.npp.1301574
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
C. Pittenger (2008)
Molecular mechanisms underlying ECT - induced amnestic deficits : A decade of research . DLN Murthy Rao Oration
C Andrade (2008)
Molecular mechanisms underlying ECT-induced amnestic deficits: A decade of research
C. Andrade (2008)
10.1016/j.pneurobio.2009.10.001
The neurobiology of brain and cognitive reserve: Mental and physical activity as modulators of brain disorders
J. Nithianantharajah (2009)
10.1016/j.euroneuro.2008.12.007
Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus
F. Chen (2009)
10.3389/neuro.08.034.2009
Exercise Can Rescue Recognition Memory Impairment in a Model with Reduced Adult Hippocampal Neurogenesis
Pauline Lafênetre (2010)
10.1111/j.1600-0447.2009.01529.x
An update on the role of glutamate in the pathophysiology of depression
N. D. Mitchell (2010)
10.1016/j.neuron.2010.03.035
Direct Current Stimulation Promotes BDNF-Dependent Synaptic Plasticity: Potential Implications for Motor Learning
B. Fritsch (2010)
10.1503/jpn.100002
Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment.
N. Malykhin (2010)
10.4103/0973-1229.58825
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
C. Andrade (2010)
10.1016/j.biopsych.2009.11.021
Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
W. Drevets (2010)
Safety and efficacy of repeated-dose intravenous ketamine for Andrade and Rao.: Antidepressants and neuroplasticity
M Aan het Rot (2010)
10.1007/978-1-908517-18-0_1
Neuroplasticity — A New Approach to the Pathophysiology of Depression
E. Fuchs (2011)
10.1007/978-1-908517-18-0_5
Clinical Consequences of the Role of Glutamate and Neuroplasticity in Depressive Disorder
P. Gorwood (2011)
10.1016/S0084-3873(11)00373-7
Glucocorticoids in the prefrontal cortex enhance memory consolidation and impair working memory by a common neural mechanism
D. Schteingart (2011)
10.1007/978-1-908517-18-0_4
Cellular Plasticity and the Pathophysiology of Depression
T. Jay (2011)



This paper is referenced by
10.1007/s11064-021-03257-6
A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders.
Surabhi Thapliyal (2021)
10.1016/j.jneuroim.2021.577534
Serotonin and dopamine receptors profile on peripheral immune cells from patients with temporal lobe epilepsy
É. Vieira (2021)
10.1007/s40263-021-00793-1
Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report
Trisha Chakrabarty (2021)
10.1016/bs.apha.2021.03.004
Neuroimmunology of depression.
Erika Sarno (2021)
10.1016/j.bbr.2020.113066
Potential antidepressant-like effect of piperazine derivative LQFM212 in mice: Role of monoaminergic pathway and brain-derived neurotrophic factor
Lorrane K. S. Moreira (2021)
10.5498/wjp.v11.i6.201
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Hewa Artin (2021)
10.3892/etm.2021.10565
Neuroplasticity and depression: Rewiring the brain's networks through pharmacological therapy (Review)
Ioana Rădulescu (2021)
10.1016/j.bionps.2020.100018
Measures of Retinal Structure and Function as Biomarkers in Neurology and Psychiatry
S. Silverstein (2020)
10.1016/j.pneurobio.2020.101783
Platelets promote epileptic seizures by modulating brain serotonin level, enhancing neuronal electric activity, and contributing to neuroinflammation and oxidative stress
E. Kopeikina (2020)
10.1515/revneuro-2019-0073
Exploring the mechanisms of action of the antidepressant effect of the ketogenic diet
A. Ricci (2020)
10.1016/j.ajp.2020.102113
A pilot, open-label investigation of the efficacy of glucosamine for the treatment of major depression.
P. N. S. Kumar (2020)
10.1016/j.mjafi.2020.09.014
Correlation of brain-derived neurotrophic factor with severity of depression and treatment response
V. S. Chauhan (2020)
10.1007/978-981-10-0751-4_20-1
Yoga and Traditional Healing Methods in Mental Health
Shivarama Varambally (2019)
10.20319/lijhls.2019.53.4162
HOW CAN WE USE NEUROTRANSMITTERS IN EMOTION AND REWARD SYSTEM TO STUDY DEPRESSION?
Pan Zhang (2019)
10.1007/978-3-030-26921-0_4
Neural Plasticity and Its Implications for Therapy
Theodore Wasserman (2019)
Expression of Tumor Necrosis Factor-Alpha in a Chick Model of Stress Vulnerable, Treatment – Resistant Depression
M. Jourdan (2019)
Regional brain volumes and antidepressant treatment resistance in major depressive disorder
E. Wigmore (2018)
On The Future Of Antidepressant Treatments: Targeting Neurotrophic Factors And Plasticity
S. White (2018)
10.1007/s11065-018-9369-5
A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples
C. E. Prado (2018)
10.1016/j.neuroscience.2018.02.010
Quantitative Proteomic Analysis Reveals Synaptic Dysfunction in the Amygdala of Rats Susceptible to Chronic Mild Stress
M. Zhou (2018)
10.4088/JCP.17f11681
Ketamine for Depression, 3: Does Chirality Matter?
C. Andrade (2017)
10.1016/j.euroneuro.2016.11.014
Chronic vortioxetine treatment in rodents modulates gene expression of neurodevelopmental and plasticity markers
J. Waller (2017)
10.3389/fncel.2017.00305
From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
Bangshan Liu (2017)
Use of MicroRNA as the Therapeutic Targets for Treatment of Major Depressive Disorder
A. Basak (2017)
Dysregulation of Leptin in Clinical Depression
Michael J. Chen (2017)
10.1080/09540261.2016.1175419
Serum cortisol and BDNF in patients with major depression—effect of yoga
G. Naveen (2016)
10.2174/1570159X14666160106155129
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem
Ekta Franscina Pinto (2016)
10.1080/14737175.2016.1179114
Electroconvulsive therapy for post-traumatic stress disorder: efficacy, mechanisms and a hypothesis for new directions
C. Andrade (2016)
Deep brain stimulation mediates neurotrophin signaling in an animal model of antidepressant resistance
Ashlie N. Reker (2016)
Antidepressant Effect And The Possible Mechanism(S) Of Action Of Secondary Metabolites From Trichilia Monadelpha In Murine Models
J. A. Mensah (2016)
10.22377/IJGP.V9I4.583
Evaluation of anxiolytic and antidepressant effect of different dosage forms of the Guduchi
Shilpa Patil (2016)
10.1161/STROKEAHA.115.010471
Fluoxetine Maintains a State of Heightened Responsiveness to Motor Training Early After Stroke in a Mouse Model
Kwan L. Ng (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar